tert-Butyl(4-ethynylphenoxy)dimethylsilane, 98%, 250mg

(-)-Menthol>99.0%(GC)100g

3,3'-Dibromo-5,5'-bis(trimethylsilyl)-2,2'-bithiophene>98.0%(GC)1g

Methyl 4-bromo-3-(hydroxymethyl)benzoate, 97%, 5g

Imidazolyltetrafluorobromoethane, 95.0%, 250mg

Indium(III) Hydroxide>98.0%(T)25g

7-Chloropyrazolo[1,5-a]pyrimidine, 95.0%, 100g

(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one, 95.0%, 100g

trans-4-((Dimethylamino)methyl)cyclohexanamine diacetate, 97%, 250mg

(R)-3-(1-Aminoethyl)benzonitrile, 95%, 1g

GC capillary column ROTI®Cap-1, 25 m, 0.25 mm, 0.50 µm, 1 Piece(s)

(2-Chloro-3-methylphenyl)methanol, 98%, 1g

(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide 2,2,2-trifluoroacetate, 95%, 1g